2006
DOI: 10.1111/j.1440-1797.2006.00564.x
|View full text |Cite
|
Sign up to set email alerts
|

Can spot urine protein/creatinine ratio replace 24 h urine protein in usual clinical nephrology?

Abstract: Random spot urinary P/Cr predicts actual 24 h protein excretion with reasonable accuracy in patients with lower levels of protein excretion but is unreliable in patients with high protein excretion and should not be used in the clinical setting unless 24 h urine collection is unavailable.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
39
0
3

Year Published

2008
2008
2019
2019

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 71 publications
(44 citation statements)
references
References 16 publications
1
39
0
3
Order By: Relevance
“…Thus, Gai et al 27 in predicting a 24 h urine protein loss .150 mg from a PCR 11.3 mg/mmol, obtained sensitivities and specificities of 91% and 75%, respectively. Similarly Lane et al, 30 using thresholds of between 300 mg/L and 3.0 g/L to define abnormal 24 h proteinuria, obtained sensitivities between 85% and 93% and specificities between 80% and 91% at varying PCR cut-offs.…”
Section: Discussionmentioning
confidence: 99%
“…Thus, Gai et al 27 in predicting a 24 h urine protein loss .150 mg from a PCR 11.3 mg/mmol, obtained sensitivities and specificities of 91% and 75%, respectively. Similarly Lane et al, 30 using thresholds of between 300 mg/L and 3.0 g/L to define abnormal 24 h proteinuria, obtained sensitivities between 85% and 93% and specificities between 80% and 91% at varying PCR cut-offs.…”
Section: Discussionmentioning
confidence: 99%
“…First, the morning spot urine sample might not be appropriate to represent total sIgA secretion in urine; however, it is well accepted that protein/creatinine ratio in spot urine may represent 24-h proteinuria [20][21][22], therefore it is rational to use the sIgA/ creatinine ratio to reflect total sIgA secretion in urine. Secondly, the best way to evaluate disease progression in the histopathology of patients with IgAN is to perform repeat renal biopsy periodically when patients have signs of disease progression clinically; however, repeat renal biopsy is not acceptable clinically.…”
Section: R-value P-valuementioning
confidence: 99%
“…(5), (6), (7), (8) The NKF K/DOQI guidelines suggests that untimed spot urine samples should be used to detect and monitor proteinuria in children and adults, it prefers a first-morning sample, but accepts a random sample if a first-morning specimen is not available. Few studies have previously assessed agreements rather than correlations between these tests and found wide limits.…”
Section: Discussionmentioning
confidence: 99%